Lv11
38 积分 2022-06-27 加入
Biologic therapies for checkpoint inhibitor-induced cutaneous toxicities: a single-institution study of 17 consecutively treated patients
10小时前
待确认
Protective effect of bevacizumab against interstitial lung disease in non-squamous non-small-cell lung cancer: a nationwide target trial emulation study
13天前
已完结
Dynamic cytokines signature predicts survival outcome from severe Immune-related hepatitis with PD-1/PD-L1 blockade in lung cancer
27天前
已完结
Targeting CXCL9/10/11–CXCR3 axis: an important component of tumor-promoting and antitumor immunity
1个月前
已完结
The Multifaceted Roles of CXCL9 Within the Tumor Microenvironment
1个月前
已完结
Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology
1个月前
已完结
Severe Refractory Checkpoint Inhibitor‐Related Hepatitis Reversed With Anti‐Thymocyte Globulin and n‐Acetylcysteine
1个月前
已完结
Cytokine release syndrome associated with immune checkpoint inhibitors: a pharmacovigilance study based on spontaneous reports in FAERS
2个月前
已完结
Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomes
2个月前
已完结
Deep learning-assisted tumor radiomic dynamics on MRI predict pathological complete response in HCC undergoing immune-based therapy followed by hepatectomy
2个月前
已完结
皖公网安备34019202002308
